KRISTY HERNANDEZ: Open Payments
NPI 1659053312 · READING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 119 payments from 22 companies in 2025. Trend: 2023 $533 · 2024 $2,526 · 2025 $2,504
Food & beverage: $2,504
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $706 |
| AstraZeneca Pharmaceuticals LP | 20 | $373 |
| ABBVIE INC. | 18 | $341 |
| PFIZER INC. | 13 | $235 |
| Abbott Laboratories | 5 | $101 |
| Lilly USA, LLC | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 4 | $88 |
| SHIELD THERAPEUTICS INC | 2 | $67 |
| Axsome Therapeutics, Inc. | 3 | $62 |
| REVANCE THERAPEUTICS, INC. | 1 | $56 |
Products named: Ozempic, Wegovy, UBRELVY, AIRSUPRA, NURTEC ODT, FARXIGA, FREESTYLE LIBRE 3, QULIPTA.
Industry payments across PA — which companies pay providers there.
